⮝ Full datasets listing

PXD073992-1

PXD073992 is an original dataset announced via ProteomeXchange.

Dataset Summary
TitleArsenic Trioxide Acts as a Molecular Glue to Promote STUB1-Mediated NPM-ALK Degradation in ALK⁺ ALCL
DescriptionThe NPM-ALK fusion constitutively activates ALK tyrosine kinase, driving oncogenesis in anaplastic large cell lymphoma (ALCL). Although arsenic trioxide (ATO) exhibits therapeutic potential in NPM-ALK⁺ ALCL by inhibiting proliferation and inducing apoptosis, its molecular mechanism remains unclear. Here, we used a combined approach of E3 ligase library screening, ATO chemical proteomics, and NPM-ALK immunoprecipitation–mass spectrometry to reveal that ATO regulates NPM–ALK stability via the E3 ligase STUB1. Comprehensive clinical data indicate that high STUB1 expression correlates with improved prognosis in NPM-ALK⁺ ALCL patients. In ALCL cells, both ATO treatment and STUB1 overexpression induce NPM-ALK degradation and suppress cell growth. Mechanistically, ATO functions as a molecular glue that stabilizes the ternary complex of STUB1 and NPM-ALK, promoting ubiquitination at K174 and subsequent proteasomal degradation. Furthermore, structural modeling identified C83 as an arsenic-bound site in STUB1 that modulates the STUB1-NPM-ALK interface, thereby enhancing their interaction and promoting ubiquitin-mediated degradation. Moreover, STUB1 overexpression or activation by Lanatoside C or Deslanoside markedly inhibits NPM‑ALK⁺ ALCL cells proliferation and synergizes with ATO in vitro and in vivo. These findings provide novel mechanistic insight into ATO’s action in NPM‑ALK⁺ ALCL and reveal new therapeutic strategies and clinical biomarkers for patient management.
HostingRepositoryPRIDE
AnnounceDate2026-09-07
AnnouncementXMLSubmission_2026-09-07_04:20:09.410.xml
DigitalObjectIdentifier
ReviewLevelPeer-reviewed dataset
DatasetOriginOriginal dataset
RepositorySupportUnsupported dataset by repository
PrimarySubmitterWenbo Cheng
SpeciesList scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606;
ModificationListubiquitinylated lysine
InstrumentOrbitrap Fusion Lumos; Orbitrap Exploris 480
Dataset History
RevisionDatetimeStatusChangeLog Entry
02026-02-03 06:17:20ID requested
12026-09-07 04:20:10announced
Publication List
10.1186/s40164-026-00800-5;
Li G, Wang J, Ye S, Zhou L, Sun Y, Li B, Zhao Y, Ding Y, Zeng Y, Xue B, Wang G, Wang F, Luo X, Liang A, Weisberg EL, Zhang W, Lu W, Yang J, ALCL. Exp Hematol Oncol, 15(1):(2026) [pubmed]
Keyword List
submitter keyword: Deslanoside, ATO, Targeted protein degradation,NPM-ALK+ ALCL, STUB1, Combination therapy
Contact List
Jing Yang
contact affiliation1Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China
contact emailjingy@tongji.edu.cn
lab head
Wenbo Cheng
contact affiliationShanghai Omicsspace Bioteh CO., LTD
contact emailwbcheng@omicsspace.com
dataset submitter
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/09/PXD073992
PRIDE project URI
Repository Record List
[ + ]